Euroapi SAS
PAR:EAPI
Gross Margin
Euroapi SAS
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| FR |
E
|
Euroapi SAS
PAR:EAPI
|
300.9m EUR |
15%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
685B USD |
82%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
368.7B USD |
68%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK |
84%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
207B CHF |
74%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
181.7B CHF |
76%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
161.9B GBP |
82%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
192B USD |
78%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
68%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
132.8B USD |
75%
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Euroapi SAS's most recent financial statements, the company has Gross Margin of 15.5%.
You don't have any saved screeners yet